# Effects of tDCS on Fear Reversal in Patients With Anxiety Disorders

> **NCT07405463** · NA · ENROLLING_BY_INVITATION · sponsor: **Jingchu Hu** · enrollment: 140 (estimated)

## Conditions studied

- Anxiety Disorders

## Interventions

- **DEVICE:** Cathodal tDCS (rDLPFC)
- **DEVICE:** Anodal tDCS (vmPFC)
- **DEVICE:** Sham tDCS
- **DEVICE:** Anodal tDCS (lDLPFC)

## Key facts

- **NCT ID:** NCT07405463
- **Lead sponsor:** Jingchu Hu
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-12-01
- **Primary completion:** 2028-12-01
- **Final completion:** 2028-12-01
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2026-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07405463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07405463, "Effects of tDCS on Fear Reversal in Patients With Anxiety Disorders". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07405463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*